News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,728 Results
Type
Article (42667)
Company Profile (283)
Press Release (685767)
Multimedia
Podcasts (90)
Webinars (17)
Section
Business (206222)
Career Advice (2038)
Deals (35741)
Drug Delivery (117)
Drug Development (81970)
Employer Resources (173)
FDA (16604)
Job Trends (15037)
News (349131)
Policy (33226)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2616)
Accelerated approval (35)
Adcomms (25)
Allergies (146)
Alliances (50311)
ALS (171)
Alzheimer's disease (1693)
Antibody-drug conjugate (ADC) (322)
Approvals (16849)
Artificial intelligence (533)
Autoimmune disease (162)
Automation (41)
Bankruptcy (363)
Best Places to Work (11685)
BIOSECURE Act (22)
Biosimilars (201)
Biotechnology (186)
Bladder cancer (159)
Brain cancer (58)
Breast cancer (648)
Cancer (4886)
Cardiovascular disease (407)
Career advice (1722)
Career pathing (36)
CAR-T (285)
CDC (47)
Celiac Disease (2)
Cell therapy (764)
Cervical cancer (36)
Clinical research (70006)
Collaboration (1742)
Company closure (4)
Compensation (1172)
Complete response letters (63)
COVID-19 (2765)
CRISPR (95)
C-suite (870)
Cystic fibrosis (145)
Data (6297)
Decentralized trials (2)
Denatured (30)
Depression (135)
Diabetes (507)
Diagnostics (6746)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (263)
Drug pricing (189)
Drug shortages (28)
Duchenne muscular dystrophy (237)
Earnings (90448)
Editorial (61)
Employer branding (21)
Employer resources (152)
Events (118205)
Executive appointments (992)
FDA (19767)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1494)
Gene editing (203)
Generative AI (45)
Gene therapy (614)
GLP-1 (977)
Government (4785)
Grass and pollen (6)
Guidances (384)
Healthcare (18962)
HIV (62)
Huntington's disease (49)
IgA nephropathy (83)
Immunology and inflammation (266)
Immuno-oncology (60)
Indications (117)
Infectious disease (3044)
Inflammatory bowel disease (197)
Inflation Reduction Act (14)
Influenza (121)
Intellectual property (255)
Interviews (317)
IPO (16718)
IRA (51)
Job creations (3685)
Job search strategy (1439)
JPM (58)
Kidney cancer (16)
Labor market (86)
Layoffs (557)
Leadership (33)
Legal (8016)
Liver cancer (92)
Longevity (14)
Lung cancer (661)
Lymphoma (379)
Machine learning (42)
Management (59)
Manufacturing (829)
MASH (165)
Medical device (13845)
Medtech (13900)
Mergers & acquisitions (20099)
Metabolic disorders (1282)
Multiple sclerosis (164)
NASH (16)
Neurodegenerative disease (328)
Neuropsychiatric disorders (89)
Neuroscience (2952)
Neurotech (1)
NextGen: Class of 2026 (6570)
Non-profit (4545)
Now hiring (68)
Obesity (602)
Opinion (270)
Ovarian cancer (168)
Pain (200)
Pancreatic cancer (233)
Parkinson's disease (285)
Partnered (34)
Patents (510)
Patient recruitment (498)
Peanut (59)
People (59327)
Pharmaceutical (64)
Pharmacy benefit managers (29)
Phase 1 (21848)
Phase 2 (30783)
Phase 3 (22966)
Pipeline (5435)
Policy (302)
Postmarket research (2581)
Preclinical (9277)
Press Release (71)
Prostate cancer (238)
Psychedelics (50)
Radiopharmaceuticals (283)
Rare diseases (870)
Real estate (6054)
Recruiting (70)
Regulatory (24930)
Reports (53)
Research institute (2432)
Resumes & cover letters (353)
Rett syndrome (28)
RNA editing (17)
RSV (81)
Schizophrenia (151)
Series A (243)
Series B (194)
Service/supplier (11)
Sickle cell disease (99)
Special edition (22)
Spinal muscular atrophy (159)
Sponsored (43)
Startups (3671)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (86)
The Weekly (58)
Vaccines (1049)
Venture capital (89)
Weight loss (382)
Women's health (92)
Worklife (18)
Date
Today (115)
Last 7 days (541)
Last 30 days (2318)
Last 365 days (30157)
2026 (3904)
2025 (30467)
2024 (35478)
2023 (40334)
2022 (51490)
2021 (56039)
2020 (54409)
2019 (46851)
2018 (35310)
2017 (32494)
2016 (31872)
2015 (37938)
2014 (31702)
2013 (26732)
2012 (28889)
2011 (29596)
2010 (27581)
Location
Africa (750)
Alabama (84)
Alaska (7)
Arizona (310)
Arkansas (13)
Asia (40103)
Australia (6501)
California (11429)
Canada (3316)
China (1119)
Colorado (481)
Connecticut (484)
Delaware (341)
Europe (86272)
Florida (1707)
Georgia (361)
Hawaii (3)
Idaho (61)
Illinois (869)
India (70)
Indiana (527)
Iowa (23)
Japan (436)
Kansas (128)
Kentucky (41)
Louisiana (26)
Maine (72)
Maryland (1419)
Massachusetts (8215)
Michigan (328)
Minnesota (645)
Mississippi (6)
Missouri (129)
Montana (32)
Nebraska (28)
Nevada (123)
New Hampshire (79)
New Jersey (3033)
New Mexico (28)
New York (3013)
North Carolina (1472)
North Dakota (10)
Northern California (5574)
Ohio (339)
Oklahoma (22)
Oregon (42)
Pennsylvania (2306)
Puerto Rico (24)
Rhode Island (48)
South America (1125)
South Carolina (67)
South Dakota (1)
Southern California (4463)
Tennessee (178)
Texas (1756)
United States (40559)
Utah (342)
Vermont (1)
Virginia (266)
Washington D.C. (82)
Washington State (927)
West Virginia (4)
Wisconsin (110)
Wyoming (2)
728,728 Results for "sino biological inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Giuliana Rancic
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation in an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
February 1, 2026
·
3 min read
Press Releases
Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development
January 29, 2026
·
2 min read
Press Releases
Sino Biological Wins 2025 Scientist.com’s Supplier Recognition Award
Recognized for Excellence in Drug Discovery Research Services on Global R&D Sourcing Platform in 2025.
December 16, 2025
·
3 min read
Press Releases
Sino Biological’s Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughput Kinase Inhibitor Screening
January 21, 2026
·
2 min read
Mergers & acquisitions
Merck, AstraZeneca Cancer Collaborator Gets Swallowed Up by Sino Biopharm
Shanghai-based LaNova Medicines—which has captured the attention of some of the biggest Western pharmas—will be folded into fellow Chinese company Sino Biopharmaceutical in a deal worth up to $951 million.
July 16, 2025
·
1 min read
·
Tristan Manalac
Sponsored
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological
Sino Biological, Inc. has successfully concluded the acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc.
July 15, 2024
·
3 min read
Press Releases
Sino Biological Sets New Industry Standard with ProPure™ Endotoxin-Free Proteins Made in the USA
July 11, 2025
·
2 min read
Sponsored
Sino Biological’s New Center for Bioprocessing (C4B): US-Based CRO Services
In October 2023,
Sino Biological, Inc.
opened its
Center for Bioprocessing (C4B)
in Houston, Texas. The C4B represents a considerable global expansion of the company’s contract research service capabilities.
September 9, 2024
·
3 min read
Deals
Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio
Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), specializing in...
April 26, 2024
·
4 min read
Business
Sino Biological Announces Services Partnership with Rapid Novor
Sino Biological, Inc., a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext, which provides biological research reagents and related technical contract research services, is pleased to announce the formation of a services partnership with Toronto, Canada-based Rapid Novor, Inc.
March 14, 2024
·
3 min read
1 of 72,873
Next
